China Medical University Hospital

This study tests a treatment called boron neutron capture therapy (BNCT) for people with aggressive brain tumors (grade 3 or 4). It uses a special boron compound that collects in tumor cells, then a low-dose neutron beam activates it to destroy those cells while sparing healthy t…

This study tests whether adding an anti-inflammatory drug to an NMDA-enhancing agent can improve thinking and memory in people with ultra-resistant schizophrenia. About 80 adults who have not responded well to clozapine will receive the combination or a placebo. The goal is to se…

This study is testing whether high-dose omega-3 fatty acids can reduce ADHD symptoms like inattention and impulsivity in children and adolescents who are deficient in omega-3. About 100 participants will take omega-3 supplements or a placebo for 12 weeks. The goal is to see if th…

This study is testing whether a supplement called Biobran, made from rice bran, can help reduce side effects and improve quality of life in women with early-stage breast cancer (stages I–III) who are receiving chemotherapy. About 96 participants will take Biobran alongside their …

This study tests whether adding a second drug that boosts NMDA receptors to a sigma-1 receptor agonist can better reduce schizophrenia symptoms than the sigma-1 drug alone. About 90 adults with schizophrenia who did not improve on at least two antipsychotics will take the combina…

This study tests whether adding traditional Chinese medicine and acupuncture to standard Western treatment helps people with sudden hearing loss recover faster and feel better. Researchers will compare standard care alone versus combined treatment in 64 adults who recently lost h…

This study looks at whether omega-3 fatty acids can reduce depression symptoms in young people aged 12-25 with major depressive disorder. Over 12 weeks, 60 participants will take either omega-3 supplements or a placebo. Researchers will track mood changes, gut bacteria, and blood…

This study tests whether omega-3 supplements can reduce behavioral problems in children and teens with autism spectrum disorder (ASD). Over 12 weeks, 50 participants aged 6-17 will take omega-3 or a placebo. Researchers will measure changes in behavior, attention, and blood marke…

This study tests a drug that boosts NMDA activity as a standalone treatment for schizophrenia. It is for people who refuse or cannot tolerate standard antipsychotics. The trial will measure changes in symptoms like hallucinations and social withdrawal in 80 participants over seve…